血液灌流联合血液透析治疗尿毒症难治性高血压的作用  

The Effect of Hemoperfusion Combined With Hemodialysis on Refractory Hypertension in Uremia Patients

作　　者：侯俊英[1] HOU Junying(Department of Nephrology,Chifeng Hospital,Chifeng Inner Mongolia 024000,China)

机构地区：[1]内蒙古赤峰市医院肾内科,内蒙古赤峰024000

出　　处：《中国继续医学教育》2018年第13期63-65,共3页China Continuing Medical Education

摘　　要：目的研究血液灌流联合血液透析治疗对尿毒症合并难治性高血压的临床治疗。方法选取60例尿毒症合并难治性高血压患者作为研究对象。采用随机分组方法,将其分为研究组和参照组,每组各30例。研究组在常规血液透析治疗基础上,每周1次血液灌流联合血液透析治疗,参照组采用常规血液透析治疗,比较两组患者治疗后收缩压、舒张压、平均动脉压、药物使用情况等变化。结果治疗后,研究组患者收缩压、舒张压、平均动脉压、药物使用情况等,与参照组相比显著下降,差异具有统计学意义(P<0.05)。结论血液灌流联合血液透析治疗尿毒症合并难治性高血压相比血液透析治疗效果更加显著。Objective To study the clinical treatment of hemoperfusion combined with hemodialysis in the treatment of uremia with refractory hypertension.Methods 60 cases of uremic patients with refractory hypertension were selected as the study objects and they were randomly divided into study group and control group,30 patients in each group.Based on routine hemodialysis,the study group received hemoperfusion combined with hemodialysis once a week.The reference group was treated with routine hemodialysis.The changes of systolic blood pressure,diastolic blood pressure,mean arterial pressure and drug use were compared between the two groups after treatment.Results After treatment,the systolic pressure,diastolic pressure,mean arterial pressure and drug use in the study group were significantly lower than those in the reference group,and the difference was statistically significant(P<0.05).Conclusion Hemoperfusion combined with hemodialysis is more effective in the treatment of uremia and refractory hypertension compared with hemodialysis.

关 键 词：血液灌流 血液透析 尿毒症 难治性高血压 

分 类 号：R692[医药卫生—泌尿科学]